切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2016, Vol. 09 ›› Issue (06) : 371 -375. doi: 10.3877/cma.j.issn.1674-6880.2016.06.003

所属专题: 文献

论著

体外膜肺氧合治疗暴发性心肌炎患者的临床研究
胡伟航1, 刘长文1, 胡炜1, 朱英1, 王剑荣1, 刘炳炜1, 郑永科1, 陆骏1, 陈斓2,()   
  1. 1. 310006 杭州,杭州市第一人民医院危重病科
    2. 310006 杭州,杭州市第一人民医院心电功能科
  • 收稿日期:2016-04-15 出版日期:2016-12-01
  • 通信作者: 陈斓
  • 基金资助:
    浙江省医药卫生科技计划项目(2011kyb062)

Clinical study of extracorporeal membrane oxygenation in patients with fulminant myocarditis

Weihang Hu1, Changwen Liu1, Wei Hu1, Ying Zhu1, Jianrong Wang1, Bingwei Liu1, Yongke Zheng1, Jun Lu1, Lan Chen2,()   

  1. 1. Department of Critical Care Medicine, Hangzhou First People's Hospital, Hangzhou 310006, China
    2. Department of Electrocardiogram, Hangzhou First People's Hospital, Hangzhou 310006, China
  • Received:2016-04-15 Published:2016-12-01
  • Corresponding author: Lan Chen
  • About author:
    Corresponding author: Chen Lan, Email:
引用本文:

胡伟航, 刘长文, 胡炜, 朱英, 王剑荣, 刘炳炜, 郑永科, 陆骏, 陈斓. 体外膜肺氧合治疗暴发性心肌炎患者的临床研究[J/OL]. 中华危重症医学杂志(电子版), 2016, 09(06): 371-375.

Weihang Hu, Changwen Liu, Wei Hu, Ying Zhu, Jianrong Wang, Bingwei Liu, Yongke Zheng, Jun Lu, Lan Chen. Clinical study of extracorporeal membrane oxygenation in patients with fulminant myocarditis[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2016, 09(06): 371-375.

目的

探讨体外膜肺氧合(ECMO)对暴发性心肌炎(FM)患者的临床治疗效果。

方法

收集2009年9月至2015年10月入住杭州市第一人民医院危重病医学科的8例FM患者,所有患者均为常规治疗疗效不佳,遂立即行静脉-动脉模式ECMO(VA-ECMO)辅助治疗。观察患者疗效,并对患者治疗前后肌酸激酶、肌酸激酶同工酶(CKMB)、肌钙蛋白Ⅰ、天冬氨酸氨基转移酶(AST)、乳酸脱氢酶(LDH)、血肌酐、血乳酸、心胸比例及左室射血分数(LVEF)进行比较。并根据股动静脉置管法将所有患者分成外科手术组及超声组,每组4例,比较两组患者置管时间及并发症的发生情况。

结果

6例患者心功能恢复正常,成功撤机,2例患者由于心功能无法逆转最终死亡。ECMO辅助治疗后肌酸激酶[(586 ± 461)U/L vs.(90 ± 38)U/L,t = 2.721,P = 0.042]、血肌酐[(153 ± 70)μmol/L vs.(966 ± 20)μmol/L,t = 3.866,P = 0.012]、血乳酸[(6.25 ± 3.67)mmol/L vs.(1.23 ± 0.29)mmol/L,t = 3.236,P = 0.023]及LVEF[(0.21 ± 0.16)vs.(0.47 ± 0.05),t = 4.416,P = 0.007]较治疗前比较,差异均有统计学意义。同时,采用外科手术切开直视下股动静脉置管方法,所需时间为(72 ± 10)min,超声引导下紧急留置了股动静脉管,所需时间为(24 ± 5)min。两种方法比较,差异有统计学意义(t = 7.908,P = 0.004),且无其他不良反应及并发症发生。

结论

ECMO是抢救FM的一种有效机械辅助方法,且联合超声引导下的股动静脉置管技术救治效果更好。

Objective

To explore the clinical effect of the extracorporeal membrane oxygenation (ECMO) in patients with fulminant myocarditis (FM).

Methods

Observing 8 FM patients admitted to Critical Care Medicine in Hangzhou First People's Hospital from September 2009 to October 2015. All patients accepted vein-artery extracorporeal membrane oxygenation (VA-ECMO) after unsatisfactory results with conventional therapy. The levels of creatine kinase, creatine kinase isoenzyme MB (CK-MB), troponin Ⅰ (TNⅠ), aspartate aminotransferase (AST), actate dehydrogenase(LDH), serum creatinine, blood lactic acid, cardiothoracic ratio and left ventricular ejection fraction (LVEF) before and after VA-ECMO were compared. Meanwhile, all the patients were divided into the surgical group and ultraphonic group accroding to catheter of femoral arterio-venous, 4 patients in each group, and the time of insertion and the occurrence of complications were compared.

Results

Six patients were successfully weaned off and fully recovered cardiac function, while 2 patients eventually died because of heart function irreversible. The levels of creatine kinase [(586 ± 461) U/L vs. (90 ± 38) U/L, t = 2.721, P = 0.042], serum creatinine[(153 ± 70) μmol/L vs. (966 ± 20) μmol/L, t = 3.866, P = 0.012], blood lactic acid [(6.25 ± 3.67) mmol/L vs. (1.23 ± 0.29) mmol/L, t = 3.236, P = 0.023] and LVEF [(0.21 ± 0.16) vs. (0.47 ± 0.05), t = 4.416, P = 0.007] showed significant differences before and after VA-ECMO. The time of insertion in the ultraphonic group was much shorter than that in the surgical group [(24 ± 5) min vs. (72 ± 10) min, t = 7.908, P = 0.004], and no other adverse reactions and complications happened.

Conclusion

ECMO is one of the most effective mechanical circulation support devices, and combined with ultrasound can be better in FM patients.

表1 8例暴发性心肌炎患者基本情况
表2 暴发性心肌炎患者ECMO辅助治疗前后各指标的变化(±s
1
Ginsberg F,Parrillo JE. Fulminant myocarditis[J]. Crit Care Clin, 2013, 29(3): 465-483.
2
Vashist S,Singh GK. Acute myocarditis in children: current concepts and management[J]. Curr Treat Options Cardiovasc Med, 2009, 11(5): 383-391.
3
Lin KM,Li MH,Hsieh KS, et al. Impact of extracorporeal membrane oxygenation on acute fulminant myocarditis-related hemodynamic compromise arrhythmia in children[J]. Pediatr Neonatol, 2016, 57(6): 480-487.
4
Caldeira D,Lopes LR,Vaz-Carneiro A, et al. Cochrane corner: corticosteroids for viral myocarditis[J]. Rev Port Cardiol, 2015, 34(1): 65-67.
5
Isogai T,Yasunaga H,Matsui H, et al. Effect of intravenous immunoglobulin for fulminant myocarditis on inhospital mortality: propensity score analyses[J]. J Card Fail, 2015, 21(5): 391-397.
6
Shauer A,Gotsman I,Keren A, et al. Acute viral myocarditis: current concepts in diagnosis and treatment[J]. Isr Med Assoc J, 2013, 15(3): 180-185.
7
Schultheiss HP,Kuhl U,Cooper LT. The management of myocarditis[J]. Eur Heart J, 2011, 32(21): 2616-2625.
8
Ishida K,Wada H,Sakakura K, et al. Long-term follow-up on cardiac function following fulminant myocarditis requiring percutaneous extracorporeal cardiopulmonary support[J]. Heart Vessels, 2013, 28(1): 86-90.
9
Wu LL,Han B. Diagnosis and treatment of myocarditis[J]. Zhongguo Dang Dai Er Ke Za Zhi, 2014, 16(12): 1283-1288.
10
Lorusso R,Centofanti P,Gelsomino S, et al. Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience[J]. Ann Thorac Surg, 2016, 101(3): 919-926.
11
Mody K P,Takayama H,Landes E, et al. Acute mechanical circulatory support for fulminant myocarditis complicated by cardiogenic shock[J]. J Cardiovasc Transl Res, 2014, 7(2): 156-164.
12
洪军,孙仁华,屈百鸣. 经皮心肺辅助循环治疗重症心肌炎合并心源性休克七例[J/CD]. 中华危重症医学杂志:电子版, 2013, 6(1):35-37.
13
Baughman KL. Diagnosis of myocarditis: death of Dallas criteria[J]. Circulation, 2006, 113(4): 593-595.
14
Cheng R,Hachamovitch R,Kittleson M, et al. Clinical outcomes in fulminant myocarditis requiring extracorporeal membrane oxygenation: a weighted meta-analysis of 170 patients[J]. J Card Fail, 2014, 20(6): 400-406.
15
den Uil CA,Lagrand WK,van der Ent M, et al. The effects of intra-aortic balloon pump support on macrocirculation and tissue microcirculation in patients with cardiogenic shock[J]. Cardiology, 2009, 114(1): 42-46.
16
Su TW,Tseng YH,Wu TI, et al. Extracorporeal life support in adults with hemodynamic collapse from fulminant cardiomyopathies: the chance of bridging to recovery[J]. ASAIO J, 2014, 60(6): 664-669.
17
Lunz D,Philipp A,Dolch M, et al. Veno-arterial extracorporeal membrane oxygenation. Indications, limitations and practical implementation[J]. Anaesthesist, 2014, 63(8-9): 625-635.
18
胡伟航,刘长文,胡炜, 等. 体外膜肺氧合治疗暴发性心肌炎5例分析[J/CD]. 中华危重症医学杂志:电子版, 2014, 7(5):354-357.
19
Rajagopal SK,Almond CS,Laussen PC, et al. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the extracorporeal Life Support Organization registry[J]. Crit Care Med, 2010, 38(2): 382-387.
20
Nakamura T,Ishida K,Taniguchi Y, et al. Prognosis of patients with fulminant myocarditis managed by peripheral venoarterial extracorporeal membranous oxygenation support: a retrospective single-center study[J]. J Intensive Care, 2015, 3(1): 5.
21
Chiu CW,Yen HH,Chiu CC, et al. Prolonged cardiac arrest: successful resuscitation with extracorporeal membrane oxygenation[J]. Am J Emerg Med, 2013, 31(11): 1627. e5-e6.
22
Hsu KH,Chi NH,Yu HY, et al. Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience[J]. Eur J Cardiothorac Surg, 2011, 40(3): 682-688.
23
Thiagarajan RR,Brogan TV,Scheurer MA, et al. Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults[J]. Ann Thorac Surg, 2009, 87(3): 778-785.
[1] 张秋阳, 余韶芸, 潘向滢, 金家佳, 夏桦, 赵雪红. 成年体外膜肺氧合患者出血影响因素的Meta 分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 392-398.
[2] 赵洪峰, 王淑颖, 胡炜, 聂世姣, 费莹, 石尚世, 储华英, 王剑荣. 体外膜肺氧合相关血流感染危险因素及预测模型建立[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(02): 98-104.
[3] 陈婧, 姚杨, 苗继荣, 丁格, 马青, 彭伊梦, 卢洲, 康凤尔, 王胜昱. 静脉-动脉体外膜肺氧合联合主动脉内球囊反搏对心源性疾病患者病死率的影响:Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(01): 48-59.
[4] 陈娇, 王立伟, 孙斌, 张萌, 刘倩, 周美艳, 丁文平, 张伟. 体外膜肺氧合联合主动脉内球囊反搏在暴发性心肌炎救治中的应用[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(01): 6-12.
[5] 霍枫, 李智霞, 季茹, 谭晓宇, 范晓礼, 叶啟发. 以循环标准判定死亡的遗体器官捐献分类标准、实施流程及需要注意的问题[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 213-221.
[6] 中华医学会器官移植学分会. 体外膜肺氧合在遗体捐献供肾保护中的应用指南[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 148-158.
[7] 魏丁, 乔艳艳, 顾兴, 张燕, 李艳燕, 钱卫生, 潘蕾, 高永恒, 金发光. 体外膜肺氧合救治急性呼吸窘迫综合征不良预后危险因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 363-367.
[8] 王晓霞, 乌丹, 张江英, 乌雅罕, 郝颖楠, 斯日古楞. 《2023 年美国胸科学会关于成人急性呼吸窘迫综合征患者管理的临床实践指南更新》解读[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 338-343.
[9] 周帅, 张庆海, 王新, 马晓艳, 孙建霞, 王海波, 张继红. 静脉-动脉体外膜肺氧合辅助下溶栓治疗急性高危肺栓塞一例[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 298-302.
[10] 许浩, 罗亮. 体外膜肺氧合支持期间新发感染的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 292-297.
[11] 李文哲, 潘鹏飞, 崔建, 于湘友. 体外生命支持技术临床应用的伦理学问题[J/OL]. 中华重症医学电子杂志, 2024, 10(02): 97-101.
[12] 方可, 笪欢欢, 汪君, 孙瑞祥, 王涛, 李阳, 江海娇, 鲁卫华. ECMO联合肾上腺切除救治妊娠期嗜铬细胞瘤并儿茶酚胺心肌病一例并文献回顾[J/OL]. 中华重症医学电子杂志, 2023, 09(03): 304-310.
[13] 高学慧, 邹晓静, 杨小博, 尚游. 甲磺酸萘莫司他在重症患者CRRT与ECMO中抗凝应用的研究进展[J/OL]. 中华重症医学电子杂志, 2023, 09(02): 210-216.
[14] 刘亮, 肖浩, 崔晓磊, 吕宝谱, 张睿, 郑拓康, 孟庆冰, 姚冬奇, 田英平, 高恒波. 急性心肌梗死合并心源性休克患者预后因素分析97例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 183-189.
[15] 米娜瓦尔·阿不都克力木, 董吁钢, 刘晨, 薛睿聪. 氯苯唑酸治疗野生型转甲状腺素蛋白心脏淀粉样变一例[J/OL]. 中华心脏与心律电子杂志, 2024, 12(02): 119-122.
阅读次数
全文


摘要